Role of the endothelium in inflammatory bowel diseases.

Inflammatory bowel diseases (IBD) are a complex group of diseases involving alterations in mucosal immunity and gastrointestinal physiology during both initiation and progressive phases of the disease. At the core of these alterations are endothelial cells, whose continual adjustments in structure and function coordinate vascular supply, immune cell emigration, and regulation of the tissue environment. Expansion of the endothelium in IBD (angiogenesis), mediated by inflammatory growth factors, cytokines and chemokines, is a hallmark of active gut disease and is closely related to disease severity. The endothelium in newly formed or inflamed vessels differs from that in normal vessels in the production of and response to inflammatory cytokines, growth factors, and adhesion molecules, altering coagulant capacity, barrier function and blood cell recruitment in injury. This review examines the roles of the endothelium in the initiation and propagation of IBD pathology and distinctive features of the intestinal endothelium contributing to these conditions.

[1]  J. Elrod,et al.  Reciprocal Regulation of Endothelial Substrate Adhesion and Barrier Function , 2001, Microcirculation.

[2]  K. Lundin,et al.  Cytokine profiles of cultured microvascular endothelial cells from the human intestine , 1998, Gut.

[3]  D. Binion,et al.  Butyrate modulates gene and protein expression in human intestinal endothelial cells. , 2003, Biochemical and biophysical research communications.

[4]  T. Pufe,et al.  Expression of VEGF121 and VEGF165 in hypertrophic chondrocytes of the human growth plate and epiphyseal cartilage , 2002, Journal of anatomy.

[5]  B. Jeppsson,et al.  p38 Mitogen‐activated protein kinase signalling regulates vascular inflammation and epithelial barrier dysfunction in an experimental model of radiation‐induced colitis , 2010, The British journal of surgery.

[6]  A. Gewirtz,et al.  Toll like receptor-5: protecting the gut from enteric microbes , 2008, Seminars in Immunopathology.

[7]  J. Alexander,et al.  H(2)O(2)-mediated permeability II: importance of tyrosine phosphatase and kinase activity. , 2001, American journal of physiology. Cell physiology.

[8]  M. Krzystek-Korpacka,et al.  Clinical relevance of circulating midkine in ulcerative colitis , 2009, Clinical chemistry and laboratory medicine.

[9]  M. Grisham,et al.  Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[10]  J. Sun,et al.  IFN-gamma and TNF-alpha induce redistribution of PECAM-1 (CD31) on human endothelial cells. , 1995, Journal of immunology.

[11]  A. Gasbarrini,et al.  Molecular signaling blockade as a new approach to inhibit leukocyte-endothelial interactions for Inflammatory bowel disease treatment , 2009, Cell adhesion & migration.

[12]  J. Davis,et al.  Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis. , 1997, The Journal of pharmacology and experimental therapeutics.

[13]  D. Shaw,et al.  Angiogenesis blockade as a new therapeutic approach to experimental colitis , 2006, Gut.

[14]  A. M. Lefer,et al.  Role of P-selectin in microvascular leukocyte-endothelial interaction in splanchnic ischemia-reperfusion. , 1994, The American journal of physiology.

[15]  B. Yacyshyn Adhesion molecule therapeutics in IBD. , 2008, Inflammatory bowel diseases.

[16]  K. Rubin,et al.  Pericytes as collagen-producing cells in excessive dermal scarring. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[17]  E. Dejana,et al.  Immune Regulation by Microvascular Endothelial Cells: Directing Innate and Adaptive Immunity, Coagulation, and Inflammation1 , 2007, The Journal of Immunology.

[18]  S. Danese,et al.  Inflammation and Coagulation in Inflammatory Bowel Disease: The Clot Thickens , 2007, The American Journal of Gastroenterology.

[19]  S. Akira,et al.  Deletion of TLR5 results in spontaneous colitis in mice. , 2007, The Journal of clinical investigation.

[20]  S. Miura,et al.  Neutrophil elastase in colitis: more than a marker of disease activity? , 2006, Journal of gastroenterology.

[21]  D. Veale,et al.  Angiogenesis in psoriasis and psoriatic arthritis: Clues to disease pathogenesis , 2005, Current rheumatology reports.

[22]  J. S. Alexander Extracellular matrix, junctional integrity and matrix metalloproteinase interactions , 2002 .

[23]  D. Granger,et al.  Cytokine and adhesion molecule expression in SCID mice reconstituted with CD4+ T cells. , 2000 .

[24]  K. Papadakis Chemokines in inflammatory bowel disease , 2004, Current allergy and asthma reports.

[25]  The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. , 2004 .

[26]  R. Löfberg,et al.  Increased risk of cancer in ulcerative colitis: a population-based cohort study. , 1999 .

[27]  E. Kouroumalis,et al.  Serum Angiogenin in Inflammatory Bowel Disease , 2004, Digestive Diseases and Sciences.

[28]  J. Gu,et al.  COX-2 expression and tumor angiogenesis in colorectal cancer. , 2004, World Journal of Gastroenterology.

[29]  T. Koepsell,et al.  Coffee and alcohol use and the risk of ulcerative colitis. , 1989, The American journal of gastroenterology.

[30]  A. Michalsen,et al.  Activated innate immune system in irritable bowel syndrome? , 2007, Gut.

[31]  P. Choi,et al.  Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. , 1994, Gut.

[32]  Shuji Ogino,et al.  Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. , 2007, The New England journal of medicine.

[33]  B. Scallon,et al.  Validation of the interleukin‐10 knockout mouse model of colitis: antitumour necrosis factor‐antibodies suppress the progression of colitis , 2003, Clinical and experimental immunology.

[34]  D. Binion,et al.  Acquired microvascular dysfunction in inflammatory bowel disease: Loss of nitric oxide-mediated vasodilation. , 2003, Gastroenterology.

[35]  J. Tabibian,et al.  Local Thrombolysis: A Newer Approach to Treating Inflammatory Bowel Disease-related Thromboembolism , 2009, Journal of clinical gastroenterology.

[36]  J. Gisbert,et al.  Gastric angiogenesis and Helicobacter pylori infection. , 2006, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[37]  Susumu Ishida,et al.  VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2. , 2004, Investigative ophthalmology & visual science.

[38]  H. Verspaget,et al.  Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[39]  C. Mirabelli,et al.  The link between inflammatory disease and patterns of leukocyte recruitment. , 1998, Expert opinion on investigational drugs.

[40]  M. Sans,et al.  VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. , 2009, Gastroenterology.

[41]  M. Krzystek-Korpacka,et al.  Platelet-derived growth factor-BB reflects clinical, inflammatory and angiogenic disease activity and oxidative stress in inflammatory bowel disease. , 2009, Clinical biochemistry.

[42]  H. Blau,et al.  Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. , 2004, The Journal of clinical investigation.

[43]  T. Muramatsu,et al.  Midkine rescues Wilms' tumor cells from cisplatin-induced apoptosis: regulation of Bcl-2 expression by Midkine. , 2000, Journal of biochemistry.

[44]  T. Imaizumi,et al.  Regulation of CX3CL1/fractalkine expression in endothelial cells. , 2004, Journal of atherosclerosis and thrombosis.

[45]  T. Joh,et al.  Blockage of angiotensin II type 1 receptor regulates TNF-alpha-induced MAdCAM-1 expression via inhibition of NF-kappaB translocation to the nucleus and ameliorates colitis. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[46]  J. Folkman,et al.  Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action. , 2006, Experimental cell research.

[47]  J. Langhorst,et al.  Stress-related peripheral neuroendocrine–immune interactions in women with ulcerative colitis , 2007, Psychoneuroendocrinology.

[48]  Y. Wen,et al.  Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea. , 1999, Investigative ophthalmology & visual science.

[49]  K. Ley,et al.  GASTROENTEROLOGY 2006;131:1518–1529 Antibody Blockade of CCL25/CCR9 Ameliorates Early but not Late Chronic , 2022 .

[50]  E. Masini,et al.  Platelets and inflammation: Role of platelet-derived growth factor, adhesion molecules and histamine , 1997, Inflammation Research.

[51]  J. Isner,et al.  Divergence of Angiogenic and Vascular Permeability Signaling by VEGF: Inhibition of Protein Kinase C Suppresses VEGF-Induced Angiogenesis, but Promotes VEGF-Induced, NO-Dependent Vascular Permeability , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[52]  D. Podolsky,et al.  Growth factors in inflammatory bowel disease. , 1999, Inflammatory bowel diseases.

[53]  S. Walsh,et al.  Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. , 2001, The American journal of pathology.

[54]  D. Carden,et al.  Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins. , 1998, American journal of physiology. Heart and circulatory physiology.

[55]  Jacques Landry,et al.  Vascular Endothelial Growth Factor (VEGF)-driven Actin-based Motility Is Mediated by VEGFR2 and Requires Concerted Activation of Stress-activated Protein Kinase 2 (SAPK2/p38) and Geldanamycin-sensitive Phosphorylation of Focal Adhesion Kinase* , 2000, The Journal of Biological Chemistry.

[56]  H. Sudhoff,et al.  Salivary VEGF: a non-invasive angiogenic and lymphangiogenic proxy in head and neck cancer prognostication , 2008, International archives of medicine.

[57]  Xueli Yuan,et al.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.

[58]  T. Muramatsu,et al.  Midkine, a heparin-binding growth factor, promotes growth and glycosaminoglycan synthesis of endothelial cells through its action on smooth muscle cells in an artificial blood vessel model. , 2002, Journal of cell science.

[59]  R. Pierce,et al.  Matrix metalloproteinases generate angiostatin: effects on neovascularization. , 1998, Journal of immunology.

[60]  D. Binion,et al.  Sodium butyrate inhibits angiogenesis of human intestinal microvascular endothelial cells through COX‐2 inhibition , 2003, FEBS letters.

[61]  D. Binion,et al.  Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition , 2008, Gut.

[62]  M. Sans,et al.  VCAM-1, but Not ICAM-1 or MAdCAM-1, Immunoblockade Ameliorates DSS-Induced Colitis in Mice , 2000, Laboratory Investigation.

[63]  M. Zago,et al.  Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. , 2008, Experimental hematology.

[64]  A. Bousvaros,et al.  Serum Basic Fibroblast Growth Factor in Pediatric Crohn's Disease (Implications for Wound Healing) , 1997, Digestive Diseases and Sciences.

[65]  A. Sckell,et al.  The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: An intravital microscopy study in mice , 2006, BMC Cancer.

[66]  M. Parkes,et al.  Contribution of the IL‐2 and IL‐10 genes to inflammatory bowel disease (IBD) susceptibility , 1998, Clinical and experimental immunology.

[67]  B. Siegmund Targeted Therapies in Inflammatory Bowel Disease , 2009, Digestive Diseases.

[68]  M. Sans,et al.  The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease , 2009, European journal of immunology.

[69]  S. Koch,et al.  Expression of IL-12-related molecules in human intestinal microvascular endothelial cells is regulated by TLR3. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[70]  K. Takeuchi,et al.  Roles of nitric oxide (NO) and NO synthases in healing of dextran sulfate sodium-induced rat colitis. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[71]  R. Shaker,et al.  Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC). , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[72]  S. Danese,et al.  The Role of JAM‐A in Inflammatory Bowel Disease: Unrevealing the Ties That Bind , 2009, Annals of the New York Academy of Sciences.

[73]  T. Oshima,et al.  H(2)O(2)-mediated permeability: role of MAPK and occludin. , 2000, American journal of physiology. Cell physiology.

[74]  D. Latinne,et al.  Intestinal helminths: a clue explaining the low incidence of inflammatory bowel diseases in Subsaharan Africa? Potential benefits and hazards of helminth therapy. , 2006, Acta gastro-enterologica Belgica.

[75]  T. Ishikawa,et al.  Tumor formation in a mouse model of colitis-associated colon cancer does not require COX-1 or COX-2 expression. , 2010, Carcinogenesis.

[76]  S. Targan,et al.  Biologic therapy of inflammatory bowel disease. , 2002, Gastroenterology.

[77]  J. Timmermans,et al.  Influence of soluble guanylate cyclase inhibition on inflammation and motility disturbances in DSS-induced colitis. , 2008, European journal of pharmacology.

[78]  K. Stokes,et al.  Role of blood- and tissue-associated inducible nitric-oxide synthase in colonic inflammation. , 2007, The American journal of pathology.

[79]  U. Förstermann Janus-faced role of endothelial NO synthase in vascular disease: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal , 2006, Biological chemistry.

[80]  Paul Rutgeerts,et al.  CXCR1‐binding chemokines in inflammatory bowel diseases: down‐regulated IL‐8/CXCL8 production by leukocytes in Crohn's disease and selective GCP‐2/CXCL6 expression in inflamed intestinal tissue , 2004, European journal of immunology.

[81]  R. Dweik,et al.  iNOS expression in human intestinal microvascular endothelial cells inhibits leukocyte adhesion. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[82]  G. Porro,et al.  The vascularity of internal fistulae in Crohn's disease: an in vivo power Doppler ultrasonography assessment , 2002, Gut.

[83]  K Miyamoto,et al.  VEGF increases retinal vascular ICAM-1 expression in vivo. , 1999, Investigative ophthalmology & visual science.

[84]  G. Kaplan,et al.  The Role of TNFα in Ulcerative Colitis , 2007 .

[85]  T. Kucharzik,et al.  Human intestinal epithelial cells down‐regulate IL‐8 expression in human intestinal microvascular endothelial cells; role of transforming growth factor‐beta 1 (TGF‐β1) , 1998, Clinical and experimental immunology.

[86]  K. Alitalo,et al.  VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia , 2003, The Journal of cell biology.

[87]  Y. Wang,et al.  Madcam‐1 Expression and Regulation in Murine Colonic Endothelial Cells in Vitro , 2005, Inflammatory bowel diseases.

[88]  J. P. McCoy,et al.  CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood. , 2005, Blood.

[89]  T. Oshima,et al.  Regulation and distribution of MAdCAM-1 in endothelial cells in vitro. , 2001, American journal of physiology. Cell physiology.

[90]  H. Ogata,et al.  Inhibition of neutrophil elastase prevents the development of murine dextran sulfate sodium-induced colitis , 2006, Journal of Gastroenterology.

[91]  R. Russell,et al.  Neoterminal ileal blood flow after ileocolonic resection for Crohn's disease. , 1993, Gut.

[92]  S. Veldhuyzen van Zanten,et al.  Therapeutic Role for Bismuth Compounds in TNBS-Induced Colitis in the Rat , 2000, Digestive Diseases and Sciences.

[93]  P. Jani,et al.  Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier , 2006, British Journal of Ophthalmology.

[94]  J. Haerting,et al.  Anti-angiogenic therapies for metastatic colorectal cancer. , 2009, The Cochrane database of systematic reviews.

[95]  F. Rosendaal,et al.  Mutations in Clotting Factors and Inflammatory Bowel Disease , 2007, The American Journal of Gastroenterology.

[96]  J. Ambati,et al.  Alternatively spliced VEGF receptor-2 is an essential endogenous inhibitor of lymphatic vessels , 2009, Nature Medicine.

[97]  I. Sasaki,et al.  Remodeling of Vascular Wall in Crohn's Disease , 1999, Digestive Diseases and Sciences.

[98]  M. Yaar,et al.  UV induces VEGF through a TNF‐α‐independent pathway , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[99]  K. Conlon,et al.  COX-2, VEGF and tumour angiogenesis. , 2009, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[100]  B. Sands Inflammatory bowel disease: past, present, and future , 2007, Journal of Gastroenterology.

[101]  A. Gewirtz Flag in the crossroads: flagellin modulates innate and adaptive immunity , 2006, Current opinion in gastroenterology.

[102]  J. Willis,et al.  CD40-mediated immune-nonimmune cell interactions induce mucosal fibroblast chemokines leading to T-cell transmigration. , 2004, Gastroenterology.

[103]  T. Oshima,et al.  TNF-α induced endothelial MAdCAM-1 expression is regulated by exogenous, not endogenous nitric oxide , 2001, BMC gastroenterology.

[104]  P. Elliott,et al.  Inhibition of NF-kappa B activation in vitro and in vivo: role of 26S proteasome. , 1999, Methods in enzymology.

[105]  D. Binion,et al.  Mucosal angiogenesis regulation by CXCR4 and its ligand CXCL12 expressed by human intestinal microvascular endothelial cells. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[106]  T. Moreels,et al.  Gastrointestinal Parasites: Potential Therapy for Refractory Inflammatory Bowel Diseases , 2005, Inflammatory bowel diseases.

[107]  D. Ostanin,et al.  T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[108]  Hyung Jin Kim,et al.  Vascular Endothelial Growth Factor Expression of Intercellular Adhesion Molecule 1 (ICAM-1), Vascular Cell Adhesion Molecule 1 (VCAM-1), and E-selectin through Nuclear Factor-κB Activation in Endothelial Cells* , 2001, The Journal of Biological Chemistry.

[109]  M. Taketo,et al.  Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps. , 2002, Cancer research.

[110]  D. Binion,et al.  Vascular cell adhesion molecule-1 expression in human intestinal microvascular endothelial cells is regulated by PI 3-kinase/Akt/MAPK/NF-kappaB: inhibitory role of curcumin. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[111]  J. Alexander,et al.  Role of cadherin internalization in hydrogen peroxide-mediated endothelial permeability. , 1998, Free radical biology & medicine.

[112]  M. Fukuda,et al.  Role of sulfated O-glycans expressed by high endothelial venule-like vessels in pathogenesis of chronic inflammatory gastrointestinal diseases. , 2009, Biological & pharmaceutical bulletin.

[113]  J. Loscalzo,et al.  Endothelial cells in physiology and in the pathophysiology of vascular disorders. , 1998, Blood.

[114]  R. Stockbrügger,et al.  Differential Behavior of Coagulation Factor XIII in Patients with Inflammatory Bowel Disease and in Patients with Giant Cell Arteritis , 1999, Pathophysiology of Haemostasis and Thrombosis.

[115]  S. Kawachi,et al.  Cytokine and endothelial cell adhesion molecule expression in interleukin-10-deficient mice. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[116]  V. Orlova,et al.  Junctional adhesion molecule-C regulates vascular endothelial permeability by modulating VE-cadherin–mediated cell–cell contacts , 2006, The Journal of experimental medicine.

[117]  D. Binion,et al.  Mesenteric venous thrombosis in inflammatory bowel disease , 2003, American Journal of Gastroenterology.

[118]  F. Brennan,et al.  Local delivery of adenoviral vectors encoding murine interleukin 10 induces colonic interleukin 10 production and is therapeutic for murine colitis , 2003, Gut.

[119]  Hua-Lin Wu,et al.  Angiostatin antagonizes the action of VEGF-A in human endothelial cells via two distinct pathways. , 2003, Biochemical and biophysical research communications.

[120]  V. Ganta,et al.  Angiopoietin‐2 in experimental colitis , 2010, Inflammatory bowel diseases.

[121]  Z. Serfőző,et al.  Effect of IBD sera on expression of inducible and endothelial nitric oxide synthase in human umbilical vein endothelial cells. , 2006, World journal of gastroenterology.

[122]  J. Alexander,et al.  Density-dependent control of MAdCAM-1 and chronic inflammation. Focus on "Mechanisms of MAdCAM-1 gene expression in human intestinal microvascular endothelial cells". , 2005, American journal of physiology. Cell physiology.

[123]  N. Ziats,et al.  Acquired increase in leucocyte binding by intestinal microvascular endothelium in inflammatory bowel disease , 1998, The Lancet.

[124]  A. Grodzinsky,et al.  Mechanical overload induces VEGF in cartilage discs via hypoxia-inducible factor. , 2004, The American journal of pathology.

[125]  F. Brennan,et al.  IL-10 gene therapy prevents TNBS-induced colitis , 2002, Gene Therapy.

[126]  L. Claesson‐Welsh,et al.  VEGF receptor signalling ? in control of vascular function , 2006, Nature Reviews Molecular Cell Biology.

[127]  K. Chadee,et al.  Biologic Therapies Against Inflammatory Bowel Disease: A Dysregulated Immune System and the Cross Talk with Gastrointestinal Mucosa Hold the Key , 2008 .

[128]  E. Dejana,et al.  The role of junctional adhesion molecules in vascular inflammation , 2007, Nature Reviews Immunology.

[129]  Giuseppe Cirino,et al.  Akt1 is critical for acute inflammation and histamine-mediated vascular leakage , 2009, Proceedings of the National Academy of Sciences.

[130]  A. Gasbarrini,et al.  Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. , 2006, Gastroenterology.

[131]  D. Veale,et al.  Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting. , 2006, Best practice & research. Clinical rheumatology.

[132]  T. Macdonald,et al.  Characterization of the mucosal cell‐mediated immune response in IL‐2 knockout mice before and after the onset of colitis , 1997, Immunology.

[133]  Yanbing Ma,et al.  Targeting TGF‐&bgr;1 by employing a vaccine ameliorates fibrosis in a mouse model of chronic colitis , 2010, Inflammatory bowel diseases.

[134]  R. Tersigni,et al.  TGF‐β1 production in inflammatory bowel disease: differing production patterns in Crohn's disease and ulcerative colitis , 2003 .

[135]  W. Sessa Molecular control of blood flow and angiogenesis: role of nitric oxide , 2009, Journal of thrombosis and haemostasis : JTH.

[136]  U. Förstermann,et al.  Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace , 2006, Circulation.

[137]  D. Granger,et al.  Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function. , 2001, Microvascular research.

[138]  M. Dubinsky,et al.  Doppler US in patients with crohn disease: vessel density in the diseased bowel reflects disease activity. , 2000, Radiology.

[139]  K. Matsushima,et al.  CCL3-CCR5 Axis Regulates Intratumoral Accumulation of Leukocytes and Fibroblasts and Promotes Angiogenesis in Murine Lung Metastasis Process1 , 2008, The Journal of Immunology.

[140]  A. Minagar,et al.  Troglitazone, a PPAR-γ activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-α , 2005, BMC Physiology.

[141]  N. Senninger,et al.  PECAM-1 (CD 31) mediates transendothelial leukocyte migration in experimental colitis. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[142]  C. Mackay,et al.  Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. , 1997, The American journal of pathology.

[143]  C. A. de la Motte,et al.  Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. , 2003, Gastroenterology.

[144]  J. Loscalzo,et al.  Molecular Mechanisms Underlying the Proangiogenic Effect of Factor XIII , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[145]  A. Schanaider,et al.  Therapeutic and prophylactic thalidomide in TNBS-induced colitis: synergistic effects on TNF-alpha, IL-12 and VEGF production. , 2007, World journal of gastroenterology.

[146]  H. Augustin,et al.  Angiopoietins: a link between angiogenesis and inflammation. , 2006, Trends in immunology.

[147]  W. H. Percy,et al.  Experimental colitis increases blood-brain barrier permeability in rabbits. , 1999, The American journal of physiology.

[148]  K. Ley,et al.  Critical role of endothelial P-selectin glycoprotein ligand 1 in chronic murine ileitis , 2006, The Journal of experimental medicine.

[149]  K. Geboes,et al.  Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease , 2006, Inflammatory bowel diseases.

[150]  M. Ladomery,et al.  Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors , 2008, Journal of Cell Science.

[151]  S. Harper,et al.  Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor , 2005, Diabetologia.

[152]  F. Magro,et al.  Soluble Selectins, sICAM, sVCAM, and Angiogenic Proteins in Different Activity Groups of Patients with Inflammatory Bowel Disease , 2004, Digestive Diseases and Sciences.

[153]  M. Neurath,et al.  Specific Regulation of T Helper Cell 1–mediated Murine Colitis by CEACAM1 , 2004, The Journal of experimental medicine.

[154]  C. Fiocchi,et al.  Intestinal fibrosis in IBD—a dynamic, multifactorial process , 2009, Nature Reviews Gastroenterology &Hepatology.

[155]  A. Patzak,et al.  eNOS involved in colitis-induced mucosal blood flow increase. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[156]  T. Imai,et al.  Chemokines as Novel Therapeutic Targets for Inflammatory Bowel Disease , 2009, Annals of the New York Academy of Sciences.

[157]  H. Ogata,et al.  Novel pathophysiological concepts of inflammatory bowel disease , 2005, Journal of Gastroenterology.

[158]  R. Srirajaskanthan,et al.  Venous thrombosis in inflammatory bowel disease , 2005, European journal of gastroenterology & hepatology.

[159]  S. Szabó,et al.  Neutralizing Anti-Vascular Endothelial Growth Factor (VEGF) Antibody Reduces Severity of Experimental Ulcerative Colitis in Rats: Direct Evidence for the Pathogenic Role of VEGF , 2009, Journal of Pharmacology and Experimental Therapeutics.

[160]  Christopher P. Johnson,et al.  Cyclosporin A differentially inhibits multiple steps in VEGF induced angiogenesis in human microvascular endothelial cells through altered intracellular signaling , 2004, Cell Communication and Signaling.

[161]  T. Pincus,et al.  Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. , 2009, Arthritis and rheumatism.

[162]  J. P. McCoy,et al.  A unique population of effector memory lymphocytes identified by CD146 having a distinct immunophenotypic and genomic profile , 2007, BMC Immunology.

[163]  Holger Gerhardt,et al.  VEGFRs and Notch: a dynamic collaboration in vascular patterning. , 2009, Biochemical Society transactions.

[164]  S. Fais,et al.  Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease. , 1995, Gastroenterology.

[165]  M. Röcken,et al.  Angiogenesis drives psoriasis pathogenesis , 2009, International journal of experimental pathology.

[166]  P. Colville-Nash,et al.  THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN A MURINE CHRONIC GRANULOMATOUS TISSUE AIR POUCH MODEL OF ANGIOGENESIS , 1996, The Journal of pathology.

[167]  Andreas Schober,et al.  Chemokines in Atherosclerosis , Thrombosis , and Vascular Biology Series , 2008 .

[168]  J. Wallace,et al.  Hapten-induced model of chronic inflammation and ulceration in the rat colon. , 1989, Gastroenterology.

[169]  A. Gewirtz,et al.  Activation of toll‐like receptor 3 protects against DSS‐induced acute colitis , 2007, Inflammatory bowel diseases.

[170]  D. Binion,et al.  Deficient iNOS in inflammatory bowel disease intestinal microvascular endothelial cells results in increased leukocyte adhesion. , 2000, Free radical biology & medicine.

[171]  M. Aurrand-Lions,et al.  Angiogenesis and inflammation face off , 2006, Nature Medicine.

[172]  M. Franco,et al.  Effect of COX-2 inhibitor after TNBS-induced colitis in wistar rats , 2009, Journal of Molecular Histology.

[173]  M. Taketo,et al.  COX selectivity and animal models for colon cancer. , 2002, Current pharmaceutical design.

[174]  G. Banfalvi,et al.  Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease , 2005, Scandinavian journal of gastroenterology.

[175]  M. Teixeira,et al.  Role of the chemokines CCL3/MIP-1 alpha and CCL5/RANTES in sponge-induced inflammatory angiogenesis in mice. , 2009, Microvascular research.

[176]  S. Danese,et al.  Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades. , 2008, The American journal of pathology.

[177]  M. Vatn,et al.  Increased number and activation of colonic macrophages in pediatric patients with untreated Crohn's disease , 2009, Inflammatory bowel diseases.

[178]  S. Kanazawa,et al.  VEGF, basic-FGF, and TGF-β in Crohn’s disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation , 2001 .

[179]  T. Hovig,et al.  Isolation and longterm culture of human intestinal microvascular endothelial cells. , 1995, Gut.

[180]  K. Suzawa,et al.  GlcNAc6ST‐1‐mediated decoration of MAdCAM‐1 protein with L‐selectin ligand carbohydrates directs disease activity of ulcerative colitis , 2009, Inflammatory bowel diseases.

[181]  Young Sook Park [COX-2 inhibitors in inflammatory bowel disease: friends or foes?]. , 2007, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

[182]  D. Lefer,et al.  Increased disease activity in eNOS-deficient mice in experimental colitis. , 2003, Free radical biology & medicine.

[183]  A. De Benedetti,et al.  Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: Implications for tumor angiogenesis , 1996, International journal of cancer.

[184]  D. Latinne,et al.  New insights into the cellular immunology of the intestine in relation to the pathophysiology of inflammatory bowel diseases. , 2006, Acta gastro-enterologica Belgica.

[185]  K. Pritchard,et al.  Mechanisms of Endotoxin Tolerance in Human Intestinal Microvascular Endothelial Cells 1 , 2003, The Journal of Immunology.

[186]  P. Brandtzaeg,et al.  Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. , 1996, Journal of immunology.

[187]  S. Szabó,et al.  Mesalamine Restores Angiogenic Balance in Experimental Ulcerative Colitis by Reducing Expression of Endostatin and Angiostatin: Novel Molecular Mechanism for Therapeutic Action of Mesalamine , 2009, Journal of Pharmacology and Experimental Therapeutics.

[188]  C. Pothoulakis,et al.  The angiogenic effect of probiotic Bacillus polyfermenticus on human intestinal microvascular endothelial cells is mediated by IL-8. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[189]  C. Moskaluk,et al.  Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in mice. , 2001, Gastroenterology.

[190]  M. Tzardi,et al.  Increased expression of VEGF and CD146 in patients with inflammatory bowel disease. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[191]  A. Chan Can aspirin prevent colorectal cancer? , 2007, The Lancet.

[192]  R. Hershkoviz,et al.  Amelioration of experimental colitis by thalidomide. , 2001, The Israel Medical Association journal : IMAJ.

[193]  D. Binion,et al.  Human Intestinal Microvascular Endothelial Cells Express Toll-Like Receptor 5: A Binding Partner for Bacterial Flagellin , 2004, The Journal of Immunology.

[194]  M. Sans,et al.  123Iodine-labelled anti-VCAM-1 antibody scintigraphy in the assessment of experimental colitis , 2001, European journal of gastroenterology & hepatology.

[195]  P. Malfertheiner,et al.  Oxidative stress in ulcerative colitis-associated carcinogenesis. , 2008, Pathology, research and practice.

[196]  R. D'Incà,et al.  Reduced Endothelial Progenitor Cell Number and Function in Inflammatory Bowel Disease: A Possible Link to the Pathogenesis , 2009, The American Journal of Gastroenterology.

[197]  D. Ota,et al.  Angiogenic Effects of Interleukin 8 (CXCL8) in Human Intestinal Microvascular Endothelial Cells Are Mediated by CXCR2* , 2003, The Journal of Biological Chemistry.

[198]  D. Jewell,et al.  Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. , 1988, Gut.

[199]  E. Berardesca,et al.  Effective Therapy with Anti‐TNF‐α in Patients with Psoriatic Arthritis Is Associated with Decreased Levels of Metalloproteinases and Angiogenic Cytokines in the Sera and Skin Lesions , 2007, Annals of the New York Academy of Sciences.

[200]  Qiang Shen,et al.  Molecular mechanisms of endothelial hyperpermeability: implications in inflammation , 2009, Expert Reviews in Molecular Medicine.

[201]  E. Maltezos,et al.  Vascular endothelial growth factor in inflammatory bowel disease , 2003, International Journal of Colorectal Disease.

[202]  T. Aikou,et al.  Serum midkine levels are increased in patients with various types of carcinomas , 2000, British Journal of Cancer.

[203]  A. Gasbarrini,et al.  Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients , 2003, Gut.

[204]  A. Zuercher,et al.  Interactions of commensal gut microbes with subsets of B- and T-cells in the murine host. , 2004, Vaccine.

[205]  P. Tak,et al.  Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints , 2008, Annals of the rheumatic diseases.

[206]  C. A. de la Motte,et al.  Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease. , 2007, Gastroenterology.

[207]  D. Binion,et al.  Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[208]  Christopher P. Johnson,et al.  Cyclosporine A Enhances Leukocyte Binding by Human Intestinal Microvascular Endothelial Cells through Inhibition of p38 MAPK and iNOS , 2002, The Journal of Biological Chemistry.

[209]  Wendy S. Garrett,et al.  Communicable Ulcerative Colitis Induced by T-bet Deficiency in the Innate Immune System , 2007, Cell.

[210]  A. Loukas,et al.  Worms and the Treatment of Inflammatory Bowel Disease: Are Molecules the Answer? , 2008, Clinical & developmental immunology.

[211]  J. Martin Collinson,et al.  Corneal avascularity is due to soluble VEGF receptor-1 , 2006, Nature.

[212]  T. Muramatsu Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. , 2002, Journal of biochemistry.

[213]  M. Yaqoob,et al.  New flow cytometric technique for the evaluation of circulating endothelial progenitor cell levels in various disease groups. , 2006, Journal of immunological methods.

[214]  Y. Mori,et al.  Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. , 2001, Circulation research.

[215]  A. Mazar,et al.  Differential angiogenic regulation of experimental colitis. , 2006, The American journal of pathology.

[216]  A. Gutzeit,et al.  Increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease. , 1999, European journal of gastroenterology & hepatology.

[217]  J. Alexander,et al.  VEGF-A stimulation of leukocyte adhesion to colonic microvascular endothelium: implications for inflammatory bowel disease. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[218]  A. Bousvaros,et al.  Elevated Serum Vascular Endothelial Growth Factor in Children and Young Adults with Crohn's Disease , 1999, Digestive Diseases and Sciences.

[219]  Bruno C. Hancock,et al.  Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2) , 1996, Cell.

[220]  R. Ginnan,et al.  Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases. , 2008, Free radical biology & medicine.

[221]  F. Luscinskas,et al.  Monocytes Induce Reversible Focal Changes in Vascular Endothelial Cadherin Complex during Transendothelial Migration under Flow , 2000, The Journal of cell biology.

[222]  S. Szabó,et al.  Altered angiogenic balance in ulcerative colitis: a key to impaired healing? , 2006, Biochemical and biophysical research communications.

[223]  M. Hristov,et al.  Adult progenitor cells in vascular remodeling during atherosclerosis , 2008, Biological chemistry.

[224]  J. Wallace,et al.  Hapten-induced chronic colitis in the rat: alternatives to trinitrobenzene sulfonic acid. , 1995, Journal of pharmacological and toxicological methods.

[225]  D. Binion,et al.  The Intestinal Microvasculature as a Therapeutic Target in Inflammatory Bowel Disease , 2006, Annals of the New York Academy of Sciences.

[226]  M. Reed,et al.  CCL5 secreted by senescent aged fibroblasts induces proliferation of prostate epithelial cells and expression of genes that modulate angiogenesis , 2009, Journal of cellular physiology.

[227]  M. Denis,et al.  ADAM15 upregulation and interaction with multiple binding partners in inflammatory bowel disease , 2006, Laboratory Investigation.

[228]  R. Hobson,et al.  VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. , 2003, American journal of physiology. Heart and circulatory physiology.

[229]  L. Mayer,et al.  Evolving paradigms in the pathogenesis of IBD , 2009, Journal of Gastroenterology.

[230]  G. Hospers,et al.  Platelets and Granulocytes, in Particular the Neutrophils, Form Important Compartments for Circulating Vascular Endothelial Growth Factor , 2004, Angiogenesis.

[231]  P. Perrin,et al.  CD146 and its Soluble Form Regulate Monocyte Transendothelial Migration , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[232]  A. Dhillon,et al.  Granulomatous vasculitis in Crohn's disease. , 1991, Gastroenterology.

[233]  C. Benjamin,et al.  Expression of vascular adhesion molecules in inflammatory bowel disease. , 1992, Gastroenterology.